Funding Tracker/Laza Medical
Series B (structured) · Cardiovascular · United States
Laza Medical: Series B (structured)
Announced November 4, 2026
The round
The SignalUp to $160 million in structured Series B financing led by GE HealthCare funds Laza's AI-powered robotic imaging for structural heart, electrophysiology and diagnostic procedures. The figure is a ceiling for structured financing, not necessarily cash already received. The Laza Medical System is under development and not approved for commercial sale in any geography.
What Laza Medical does
AI-powered robotic ultrasound imaging for structural heart, electrophysiology and diagnostic procedures.
Laza Medical is building an intelligent ultrasound imaging system for structural heart, electrophysiology and diagnostic procedures: AI-powered real-time 3D heart modeling, echo-based procedural guidance and robotic probe control. On November 4, 2026 it announced up to $160 million in structured Series B financing led by GE HealthCare. The Laza Medical System is under development and not approved for commercial sale in any geography; the company says a first-in-human clinical study took place in 2025.
Full Laza Medical profile- Company
- Laza Medical
- Consideration
- Undisclosed
- Stage
- Series B (structured)
- Announced
- November 4, 2026
- Led by
- GE HealthCare
- Other investors
- Unorthodox Ventures, PA MedTech, AMED (returning)
- Vertical
- Cardiovascular
- Country
- United States
- Headquarters
- Los Gatos, California, United States